Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets Initiative (SBTi). The SBTi is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science and is considered the gold standard for net-zero. A core component of […]

The post Phastar Net-Zero Target Approved by the Science Based Targets Initiative first appeared on World Pharma Today.